GEODON

Adverse Events

Drug Profile

Learn More

Reference

About Results

Comments

Geodon Adverse Events Reported to the FDA Over Time

How are Geodon adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Geodon, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Geodon is flagged as the suspect drug causing the adverse event.

Most Common Geodon Adverse Events Reported to the FDA

What are the most common Geodon adverse events reported to the FDA?

Somnolence	581 (1.63%)
Tardive Dyskinesia	546 (1.54%)
Insomnia	531 (1.49%)
Tremor	527 (1.48%)
Drug Ineffective	503 (1.42%)
Anxiety	481 (1.35%)
Weight Increased	455 (1.28%)
Feeling Abnormal	451 (1.27%)
Depression	414 (1.16%)
Agitation	400 (1.13%)
Dystonia	372 (1.05%)
	Show More
Fatigue	331 (.93%)
Dyskinesia	319 (.9%)
Dyspnoea	317 (.89%)
Dizziness	314 (.88%)
Nausea	299 (.84%)
Suicidal Ideation	289 (.81%)
Extrapyramidal Disorder	278 (.78%)
Completed Suicide	270 (.76%)
Neuroleptic Malignant Syndrome	263 (.74%)
Electrocardiogram Qt Prolonged	260 (.73%)
Weight Decreased	256 (.72%)
Aggression	246 (.69%)
Psychotic Disorder	240 (.68%)
Headache	239 (.67%)
Drug Interaction	236 (.66%)
Convulsion	234 (.66%)
Malaise	225 (.63%)
Vomiting	221 (.62%)
Loss Of Consciousness	216 (.61%)
Mania	216 (.61%)
Sedation	208 (.59%)
Death	198 (.56%)
Hallucination	197 (.55%)
Hypertension	190 (.53%)
Confusional State	189 (.53%)
Suicide Attempt	188 (.53%)
Fall	183 (.51%)
Overdose	176 (.5%)
Rash	175 (.49%)
Paranoia	174 (.49%)
Abnormal Behaviour	173 (.49%)
Restlessness	173 (.49%)
Gait Disturbance	168 (.47%)
Asthenia	163 (.46%)
Akathisia	162 (.46%)
Condition Aggravated	162 (.46%)
Vision Blurred	157 (.44%)
Pain	152 (.43%)
Speech Disorder	148 (.42%)
Nervousness	147 (.41%)
Withdrawal Syndrome	147 (.41%)
Muscle Spasms	145 (.41%)
Heart Rate Increased	142 (.4%)
Swollen Tongue	142 (.4%)
Pyrexia	140 (.39%)
Cardiac Arrest	138 (.39%)
Hyperhidrosis	138 (.39%)
Mental Disorder	137 (.39%)
Diarrhoea	136 (.38%)
Syncope	134 (.38%)
Bipolar Disorder	133 (.37%)
Dysphagia	132 (.37%)
Hypersensitivity	131 (.37%)
Musculoskeletal Stiffness	131 (.37%)
Paraesthesia	131 (.37%)
Memory Impairment	129 (.36%)
Hallucination, Auditory	124 (.35%)
Chest Pain	123 (.35%)
Blood Glucose Increased	118 (.33%)
Myocardial Infarction	116 (.33%)
Panic Attack	116 (.33%)
Dysarthria	112 (.32%)
Palpitations	111 (.31%)
Diabetes Mellitus	110 (.31%)
Incorrect Dose Administered	109 (.31%)
Constipation	107 (.3%)
Drug Dependence	107 (.3%)
Delusion	106 (.3%)
Disorientation	103 (.29%)
Hypoaesthesia	102 (.29%)
Crying	101 (.28%)
Irritability	100 (.28%)
Blood Pressure Increased	99 (.28%)
Thinking Abnormal	99 (.28%)
Activities Of Daily Living Impaired	98 (.28%)
Rhabdomyolysis	97 (.27%)
Cardio-respiratory Arrest	96 (.27%)
Hypotension	94 (.26%)
Tachycardia	94 (.26%)
Cardiac Disorder	91 (.26%)
Drug Withdrawal Syndrome	91 (.26%)
Dry Mouth	91 (.26%)
Lethargy	91 (.26%)
Treatment Noncompliance	90 (.25%)
Muscle Twitching	88 (.25%)
Disturbance In Attention	87 (.24%)
Visual Impairment	87 (.24%)
Arrhythmia	85 (.24%)
Blood Creatine Phosphokinase Increa...	85 (.24%)
Amnesia	83 (.23%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Geodon, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Geodon is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Geodon

What are the most common Geodon adverse events reported to the FDA?

Neurological	2947 (8.29%)
Movement Disorders	2596 (7.3%)
Anxiety Disorders	1520 (4.28%)
Therapeutic And Nontherapeutic Effe...	1106 (3.11%)
Gastrointestinal Signs	898 (2.53%)
Cardiac Arrhythmias	871 (2.45%)
Respiratory	832 (2.34%)
Suicidal And Self-injurious Behavio...	832 (2.34%)
Cardiac And Vascular Investigations	805 (2.27%)
Physical Examination Topics	804 (2.26%)
Medication Errors	745 (2.1%)
	Show More
Sleep Disorders	735 (2.07%)
Muscle	731 (2.06%)
Disturbances In Thinking	683 (1.92%)
Personality Disorders	604 (1.7%)
Depressed Mood Disorders	536 (1.51%)
Psychiatric	512 (1.44%)
Epidermal And Dermal Conditions	489 (1.38%)
Mental Impairment	453 (1.27%)
Mood Disorders	409 (1.15%)
Neuromuscular	407 (1.15%)
Injuries	404 (1.14%)
Manic And Bipolar Mood Disorders	402 (1.13%)
Schizophrenia And Other Psychotic	393 (1.11%)
Lifestyle Issues	391 (1.1%)
Musculoskeletal And Connective Tiss...	373 (1.05%)
Deliria	353 (.99%)
Vision	330 (.93%)
Infections - Pathogen Unspecified	323 (.91%)
Seizures	321 (.9%)
Changes In Physical Activity	303 (.85%)
Headaches	297 (.84%)
Gastrointestinal Motility And Defec...	293 (.82%)
Fatal Outcomes	292 (.82%)
Skin Appendage Conditions	289 (.81%)
Appetite And General Nutritional	253 (.71%)
Tongue Conditions	249 (.7%)
Allergic Conditions	248 (.7%)
Cardiac Disorder Signs	241 (.68%)
Psychiatric And Behavioural Symptom...	226 (.64%)
Sexual Function And Fertility	225 (.63%)
Metabolic, Nutritional And Blood Ga...	219 (.62%)
Hepatobiliary	218 (.61%)
Urinary Tract Signs	209 (.59%)
Glucose Metabolism Disorders	199 (.56%)
Vascular Hypertensive	196 (.55%)
Coronary Artery	195 (.55%)
Hematology Investigations	177 (.5%)
Decreased And Nonspecific Blood Pre...	174 (.49%)
Body Temperature Conditions	166 (.47%)
Ocular Neuromuscular	164 (.46%)
Electrolyte And Fluid Balance Condi...	158 (.44%)
Chemical Injury And Poisoning	148 (.42%)
Lipid Analyses	145 (.41%)
Salivary Gland Conditions	141 (.4%)
Enzyme	138 (.39%)
Water, Electrolyte And Mineral	137 (.39%)
Renal Disorders	135 (.38%)
Endocrine Investigations	128 (.36%)
Central Nervous System Vascular	127 (.36%)
Hepatic And Hepatobiliary	125 (.35%)
Bone And Joint Injuries	121 (.34%)
Joint	119 (.33%)
Renal And Urinary Tract Investigati...	119 (.33%)
Toxicology And Therapeutic Drug Mon...	116 (.33%)
Eye	113 (.32%)
Breast	96 (.27%)
Sleep Disturbances	96 (.27%)
Upper Respiratory Tract Disorders	94 (.26%)
Oral Soft Tissue Conditions	91 (.26%)
Communication Disorders	79 (.22%)
Myocardial	75 (.21%)
Menstrual Cycle And Uterine Bleedin...	74 (.21%)
Cranial Nerve Disorders	61 (.17%)
Viral Infectious	61 (.17%)
White Blood Cell	61 (.17%)
Therapeutic Procedures And Supporti...	59 (.17%)
Vascular	56 (.16%)
Product Quality Issues	55 (.15%)
Acid-base	54 (.15%)
Exocrine Pancreas Conditions	51 (.14%)
Gastrointestinal Therapeutic Proced...	50 (.14%)
Inner Ear And Viiith Cranial Nerve	50 (.14%)
Sexual Dysfunctions, Disturbances A...	49 (.14%)
Bronchial Disorders	48 (.14%)
Legal Issues	47 (.13%)
Thyroid Gland	45 (.13%)
Gastrointestinal Conditions	43 (.12%)
Angiedema And Urticaria	42 (.12%)
Bone Disorders	41 (.12%)
Dental And Gingival Conditions	41 (.12%)
Hypothalamus And Pituitary Gland	41 (.12%)
Lower Respiratory Tract Disorders	40 (.11%)
Gastrointestinal Hemorrhages	38 (.11%)
Pulmonary Vascular	37 (.1%)
Arteriosclerosis, Stenosis, Vascula...	34 (.1%)
Ocular Sensory Symptoms	33 (.09%)
Eating Disorders	32 (.09%)
Heart Failures	32 (.09%)
Investigations, Imaging And Histopa...	32 (.09%)
Hearing	31 (.09%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Geodon, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Geodon is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Geodon According to Those Reporting Adverse Events

Why are people taking Geodon, according to those reporting adverse events to the FDA?

Bipolar Disorder	1599
Schizophrenia	913
Ill-defined Disorder	634
Depression	480
Psychotic Disorder	467
Schizoaffective Disorder	377
	Show More
Bipolar I Disorder	251
Drug Use For Unknown Indication	226
Anxiety	181
Agitation	166
Product Used For Unknown Indication	164
Affective Disorder	139
Mania	126
Major Depression	123
Schizophrenia, Paranoid Type	115
Mental Disorder	85
Paranoia	83
Obsessive-compulsive Disorder	78
Post-traumatic Stress Disorder	73
Aggression	65
Bipolar Ii Disorder	65
Mood Swings	58
Hallucination	56
Hallucination, Auditory	50
Insomnia	47
Sleep Disorder	39
Delusion	35
Attention Deficit/hyperactivity Dis...	31
Abnormal Behaviour	31
Dementia	29
Nervousness	29
Thinking Abnormal	25
Anxiety Disorder	24
Borderline Personality Disorder	22
Autism	21
Mood Altered	20
Suicide Attempt	19
Personality Disorder	18
Confusional State	18
Anger	17
Suicidal Ideation	16
Generalised Anxiety Disorder	15
Dementia Alzheimers Type	15
Aspergers Disorder	15
Schizoaffective Disorder Bipolar Ty...	13
Tourettes Disorder	12
Psychotic Behaviour	12
Panic Attack	11
Acute Psychosis	11
Delirium	10
Restlessness	10

Drug Labels

Label	Labeler	Effective
Geodon	State of Florida DOH Central Pharmacy	01-JUN-10
Geodon	Physicians Total Care, Inc.	29-JUN-10
Geodon	STAT RX USA LLC	09-JUL-10
Geodon	Rebel Distributors Corp	28-SEP-10
Geodon	Lake Erie Medical DBA Quality Care Products LLC	05-NOV-10
Geodon	Unit Dose Services	06-DEC-10
Geodon	REMEDYREPACK INC.	20-DEC-10
Geodon	REMEDYREPACK INC.	20-DEC-10
Geodon	REMEDYREPACK INC.	20-DEC-10
Geodon	REMEDYREPACK INC.	20-DEC-10
Geodon	Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC	27-MAR-12
Geodon	Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC	11-JUN-12
Geodon	Cardinal Health	28-JUN-12
Geodon	Roerig	08-MAR-13

Geodon Case Reports

What Geodon safety concerns are being reported by doctors and researchers in the medical literature?

About Results

This report contains aggregated drug side effects and adverse events for Geodon. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Geodon.